Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
Clinical trial NCT03482102 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03482102
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2024-02-28
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.